Document:

grts-ex101_78.htm

 

 

 

 

Exhibit 10.1

 

Second Amendment to License Agreement

 

This Second Amendment to License Agreement (“Second Amendment”), is made as of May 20, 2020 (“Effective Date”) by and between Gritstone Oncology, Inc. (“Licensee”) and MIL 21E, LLC (“Licensor”).

 

WHEREAS, Licensor and Licensee are parties to a certain License Agreement dated September 6, 2018, as amended by a certain First Amendment to License Agreement dated July 11, 2019 (together, “Agreement”);

 

WHEREAS, Licensee warrants and represents that, to the best of its knowledge, Licensor has fulfilled its obligations under the Agreement and is not in default of any covenants or obligations contained in the Agreement;

 

WHERAS, Licensee and Licensor desire to amend the Agreement in certain respects as set forth herein; and,

 

WHEREAS, all capitalized terms used herein but not defined herein shall have the meaning ascribed to them in the Agreement.

 

For good and valuable consideration, the receipt and legal sufficiency of which are hereby acknowledged, accepted and agreed to, Licensor and Licensee agree that the following shall be effective as of the Effective Date:

 

Section 2(a) of the Agreement is modified by adding this new paragraph to the end of the Section:

 

The Term of the Agreement shall be extended by twelve (12) months (“Extended Term”) from September 1, 2021 and the Expiration Date of the Agreement shall be modified to August 31, 2022 (“Expiration Date”).

 

 

Section 2(c) of the Agreement is modified by adding the following as the final paragraph of this Section:

 

Licensee, upon six (6) months' written notice to Licensor shall have the right to terminate the Extended Term early ("Extended Term Early Termination"); provided, however, that such Extended Term Early Termination can be no sooner than eight (8) months from September 1, 2021, or at the earliest, May 1, 2022. Licensor has no obligation to honor any Early Termination notice that does not strictly comply with the requirements of this Section 2(c).

 

1
 

 

 

 

 

Section 3(a) of the Agreement is modified by adding this new paragraph to the end of the Section:

 

The License Fee amount shall be modified for the Extended Term and Licensee shall pay a monthly license fee equal to $296,145.26 (“License Fee”) commencing on September 1, 2021, which shall be paid in advance on or before the first (1st) day of each and every month during the Extended Term. Licensee shall pay each License Fee payment by electronic payment to Licensor.

 

Section 3(e) of the Agreement is modified by adding this new paragraph to the end of the Section:

 

Licensee shall pay, immediately upon executing this Amendment, an amount equal to the License Fee for the last month of the Extended Term of this Agreement ($296,145.26), and a Security Deposit equal to $296,145.26.   Licensee has already paid Licensor: (i)

$279,145.31 for the Security Deposit which shall be applied to the Extended Term Security  Deposit  resulting  in  an  outstanding  amount  owed  of  $16,999.95;  and  (ii)

$279,145.31 for the last month’s license fee which shall be applied to the Extended Term last month’s license fee resulting in an amount owed of $16,999.95. As such, Licensee shall pay a total of $33,999.90, on or before the execution of this Amendment.

 

 

Ratification. As hereby amended, the Agreement is ratified, approved and confirmed in all respects. In the event that any of the provisions of the Agreement are inconsistent with this Second Amendment or the state of facts contemplated hereby, the provisions of this Second Amendment shall control. Except as expressly set forth herein, all other terms and conditions in the agreement remain unmodified.

 

IN WITNESS WHEREOF, Licensor and Licensee have duly executed this Second Amendment as of the day and year first above written.

 

 

	
LICENSOR:

 

MIL 21E, LLC

 

  /s/ Amrit Chaudhuri                           
	
 
	
LICENSEE:

 

GRITSTONE ONCOLOGY, INC.

 

  /s/ Andrew Allen                              

	
By:Amrit Chaudhuri

Title:CEO

May 22, 2020
	
 
	
By:Andrew Allen, MD, PhD

Title:President & Chief Executive Officer

May 22, 2020Exhibit 4.1
SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE No. 2 (this “Supplemental Indenture”), dated as of May 21, 2020 among Maxar Technologies Inc., a Delaware corporation (the “Company”), and Wilmington Trust, National Association, as trustee (the “Trustee”).
W I T N E S S E T H
WHEREAS, SSL Robotics LLC, a Delaware limited liability company (the “Escrow Issuer”), and the Trustee, among others, have heretofore executed and delivered an indenture (the “Indenture”), dated as of December 2, 2019 providing for the issuance of the Escrow Issuer’s 9.750% Senior Secured Notes due 2023 (the “Notes”);
WHEREAS, pursuant to a supplemental indenture dated as of December 11, 2019, the Company agreed to assume all rights and obligations of the Escrow Issuer under the Notes and the Indenture (the “Assumption”) by executing Supplemental Indenture no. 1;
WHEREAS, pursuant to Section 9.01(x)(17) of the Indenture, the Company is authorized to amend the Indenture to conform the text of the Indenture to any provision of the “Description of Notes” section of the Company’s Offering Memorandum dated November 15, 2019 (the “Description of Notes”) to the extent that such provision in the Description of Notes was intended to be a verbatim recitation of a provision of the Indenture; and
WHEREAS, the “Subsidiary Guarantees—Release of Subsidiary Guarantees” section of the Description of Notes was intended to be a verbatim recitation of a provision of the Indenture
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders as follows:
1.         CAPITALIZED TERMS.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.         AMENDMENT. (a) Section 10.06 of the Indenture is hereby amended and replaced in its entirety by the below text:
“     A Subsidiary Guarantee by a Subsidiary Guarantor shall be automatically and unconditionally released and discharged, and no further action by such Subsidiary Guarantor, the Company or the Trustee is required for the release of such Subsidiary Guarantor’s Subsidiary Guarantee, upon:
(1)   the occurrence of any sale, exchange, transfer or other disposition (by merger, amalgamation, consolidation or otherwise) of all of the Capital Stock of such Subsidiary Guarantor (including any sale, exchange, transfer or other disposition after which the applicable Subsidiary Guarantor is no longer a Restricted Subsidiary) or of all or substantially all of the assets and property of such Subsidiary Guarantor, which sale, exchange, transfer or other disposition is made in compliance with the applicable provisions of this Indenture (to the extent such provisions are required to be satisfied as of the
​

1

date of the transaction); provided that such Subsidiary Guarantor is also released from all of its obligations in respect of the Senior Credit Facilities;
(2)   the release or discharge of such Subsidiary Guarantor from its Guarantee of Indebtedness of the Company and the Subsidiary Guarantors under the Senior Credit Facilities, except (i) a discharge or release by or as a result of payment under such Guarantee (it being understood that a release subject to a contingent reinstatement is still a release, and that if any such Guarantee is so reinstated, such Subsidiary Guarantee shall also be reinstated to the extent that such Subsidiary Guarantor would then be required to Guarantee the Notes pursuant to this Indenture) and (ii) a discharge or release by or as a result of an amendment, modification or waiver of the provision in respect of minimum guarantor coverage set forth in Section 10.1(17) of the Senior Credit Facilities as in effect on the Issue Date (or defaults arising thereunder) requiring consent of the lenders under the Senior Credit Facilities;
(3)   the designation of any Restricted Subsidiary that is a Subsidiary Guarantor as an Unrestricted Subsidiary in compliance with Section 4.17;
(4)   upon such Person becoming an Excluded Subsidiary or Non- Recourse Subsidiary, in each case as a result of a transaction or designation permitted by this Indenture;
(5)   the Company exercising its Legal Defeasance option or Covenant Defeasance option as set forth in Article 8 or the Company’s obligations under this Indenture being discharged in accordance with the terms of this Indenture;
(6)   upon the full and final payment of all Pari Passu Lien Notes Obligations of the Company and such Subsidiary Guarantor; or
(7)   as described in Section 4.15(b).
The Company will notify the Trustee in writing in respect of any release of a Subsidiary Guarantee; provided that such notification will not be a condition to the effectiveness of such lease.”
(b) As of the date hereof, the “Corporate Trust Office” shall be located at:
246 Goose Lane, Suite 105
Guilford, Connecticut 06437
3.         THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAW OF THE STATE OF NEW YORK.
4.         COUNTERPARTS.  The parties may sign any number of copies of this Supplemental Indenture.  Each signed copy shall be an original, but all of them together represent the same agreement.  Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.
5.         EFFECT OF HEADINGS.  The Section headings herein are for convenience only and shall not affect the construction hereof.
​

2

6.         THE TRUSTEE.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company.
[Signature Pages Follow]
​
​

3

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.
	​

	​

	​

	​

	​
	   
	MAXAR TECHNOLOGIES INC.,

	​
	​
	        as Company

	​
	​
	​

	​
	​
	By:
	/s/ Randall H. Lynch

	​
	​
	Name:
	Randall H. Lynch

	​
	​
	Title:
	Senior Vice President and Treasurer

​
​

[Signature Page to Supplemental Indenture No. 2]

​
	​

	​

	​

	​

	​
	   
	WILMINGTON TRUST, NATIONAL ASSOCIATION
as Trustee

	​
	​
	​
	​

	​
	​
	By:
	/s/ Nedine P. Sutton

	​
	​
	​
	Name:  Nedine P. Sutton

	​
	​
	​
	Title:  Vice President

​

[Signature Page to Supplemental Indenture No. 2]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00312-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00312-of-00352.parquet"}]]